Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

 

Federal Register Notices > Manufacturers 2008 > Johnson Matthey, Inc

Notice of Registration - 2008


FR Doc E8-6379[Federal Register: March 28, 2008 (Volume 73, Number 61)] [Notices] [Page 16711] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr28mr08-110]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated December 17, 2007, and published in the Federal Register on December 27, 2007, (72 FR 73359), Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066-1742, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:

Drug Schedule
Tetrahydrocannabinols (7370)  I
Dihydromorphine (9145)  I
Difenoxin (9168)  I
Propiram (9649)  I
Amphetamine (1100)  II
Methamphetamine (1105)  II
Methylphenidate (1724)  II
Nabilone (7379)  II
Cocaine (9041)  II
Codeine (9050)  II
Dihydrocodeine (9120)  II
Oxycodone (9143)  II
Hydromorphone (9150)  II
Ecgonine (9180)  II
Hydrocodone (9193)  II
Meperidine (9230)  II
Methadone (9250)  II
Methadone intermediate (9254)  II
Morphine (9300)  II
Thebaine (9333)  II
Oxymorphone (9652)  II
Noroxymorphone (9668)  II
Alfentanil (9737)  II
Remifentanil (9739)  II
Sufentanil (9740)  II
Fentanyl (9801)  II

The company plans to manufacture the listed controlled substances in bulk for sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Johnson Matthey, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with State and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: March 19, 2008.

Joseph T. Rannazzisi, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. E8-6379 Filed 3-27-08; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).


     HOME

CONTACT US

SEARCH

BACK TO TOP